Cenovus Energy Inc (CVE) 13.69 $CVE 23.0% Return Seen to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cenovus Energy Inc (CVE) 13.69 $CVE

23.0% Return Seen to Date on SmarTrend Cenovus Energy Call (CVE)
Comtex SmarTrend(R) - Thu Jun 16, 3:05AM CDT
SmarTrend identified an Uptrend for Cenovus Energy (NYSE:CVE) on March 1st, 2016 at $11.61. In approximately 4 months, Cenovus Energy has returned 23.00% as of today's recent price of $14.28.
CVE: 13.69 (-0.17)

Morning Briefing on Oil & Gas Drilling & Exploration Stocks -- Vanguard Natural Resources, Cenovus Energy, Helmerich & Payne, and W&T Offshore
PR Newswire - Wed Jun 15, 7:35AM CDT
On Tuesday, June 14, 2016, the NASDAQ Composite ended the trading session at 4,843.55, down 0.10%; the Dow Jones Industrial Average edged 0.33% lower to finish at 17,674.82; and the S&P 500 closed at 2,075.32, down 0.18%. Stock-Callers.com has initiated coverage on the following equities: Vanguard Natural Resources LLC (NASDAQ: VNR), Cenovus Energy Inc. (NYSE: CVE), Helmerich & Payne Inc. (NYSE: HP), and W&T Offshore Inc. (NYSE: WTI). Learn more about these stocks by accessing their free trade alerts at:
WTI: 2.17 (-0.01), HP: 66.17 (-0.28), CVE: 13.69 (-0.17), VNR: 1.37 (-0.02)

Cenovus Energy Shares Up 37.6% Since SmarTrend's Buy Recommendation (CVE)
Comtex SmarTrend(R) - Wed Jun 08, 1:06PM CDT
SmarTrend identified an Uptrend for Cenovus Energy (NYSE:CVE) on March 1st, 2016 at $11.61. In approximately 3 months, Cenovus Energy has returned 37.64% as of today's recent price of $15.98.
CVE: 13.69 (-0.17)

Shares of CVE Up 29.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jun 01, 12:42AM CDT
SmarTrend identified an Uptrend for Cenovus Energy (NYSE:CVE) on March 1st, 2016 at $11.61. In approximately 3 months, Cenovus Energy has returned 29.89% as of today's recent price of $15.08.
CVE: 13.69 (-0.17)

Cenovus to present at the UBS Global Oil and Gas Conference
CNW Group - Tue May 24, 9:30AM CDT
Harbir Chhina, Executive Vice-President, Oil Sands Development, will present at the UBS Global Oil and Gas Conference in Austin, Texas, on Wednesday, May 25, 2016 at 7:40 a.m. MT (8:40 a.m. CT).
CVE: 13.69 (-0.17), CVE.TO: 17.94 (-0.09)

Cenovus Energy Up 32.5% Since SmarTrend Uptrend Call (CVE)
Comtex SmarTrend(R) - Tue May 17, 1:18AM CDT
SmarTrend identified an Uptrend for Cenovus Energy (NYSE:CVE) on March 1st, 2016 at $11.61. In approximately 3 months, Cenovus Energy has returned 32.47% as of today's recent price of $15.38.
CVE: 13.69 (-0.17)

Cenovus Energy Shares Up 22.2% Since SmarTrend's Buy Recommendation (CVE)
Comtex SmarTrend(R) - Mon May 09, 1:53PM CDT
SmarTrend identified an Uptrend for Cenovus Energy (NYSE:CVE) on March 1st, 2016 at $11.61. In approximately 2 months, Cenovus Energy has returned 22.18% as of today's recent price of $14.19.
CVE: 13.69 (-0.17)

Uptrend Call Working As Cenovus Energy Stock Rises 33.8% (CVE)
Comtex SmarTrend(R) - Fri Apr 29, 1:06AM CDT
SmarTrend identified an Uptrend for Cenovus Energy (NYSE:CVE) on March 1st, 2016 at $11.61. In approximately 2 months, Cenovus Energy has returned 33.76% as of today's recent price of $15.53.
CVE: 13.69 (-0.17)

Cenovus reports voting results of election of Directors
PR Newswire - Wed Apr 27, 7:25PM CDT
Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) announced that at its annual meeting of shareholders held on April 27, 2016, each of the 11 nominees proposed as Directors and listed in its Management Information Circular dated March 4, 2016 were elected as Directors. The detailed results of the vote are set out below.
CVE: 13.69 (-0.17), CVE.TO: 17.94 (-0.09)

Cenovus finishes first quarter with strong balance sheet
CNW Group - Wed Apr 27, 5:00AM CDT
Company's 2016 cost-reduction initiatives on target
CVE: 13.69 (-0.17), CVE.TO: 17.94 (-0.09)

1 Key Cenovus Energy Stock Number You Must Know
Matthew DiLallo, The Motley Fool - Motley Fool - Thu Apr 21, 11:32AM CDT
Image Source: Cenovus Energy. On the surface it would seem like Cenovus Energy 's financial situation is really starting to deteriorate. Amid weakening oil prices and credit conditions the company has had to make significant reductions to its...
COP: 42.45 (+0.15), CVE: 13.69 (-0.17)

Cenovus to hold conference call and webcast on first quarter 2016 results
CNW Group - Wed Apr 20, 9:33AM CDT
Annual meeting of shareholders to take place in Calgary
CVE: 13.69 (-0.17), CVE.TO: 17.94 (-0.09)

How Safe Is Cenovus Energy Inc. Stock?
Matthew DiLallo, The Motley Fool - Motley Fool - Mon Apr 18, 11:29AM CDT
Image Source: Suncor Energy  Canadian oil producer Cenovus Energy has been hard hit by the downturn in oil prices. Those prices have cut deeply into the company's cash flow, which has forced it to cut deeply into its outflows, slashing its...
SU: 27.69 (-0.15), CVE: 13.69 (-0.17)

19.8% Return Seen to Date on SmarTrend Cenovus Energy Call (CVE)
Comtex SmarTrend(R) - Thu Apr 14, 1:23AM CDT
SmarTrend identified an Uptrend for Cenovus Energy (NYSE:CVE) on March 1st, 2016 at $11.61. In approximately 1 month, Cenovus Energy has returned 19.81% as of today's recent price of $13.91.
CVE: 13.69 (-0.17)

The Biggest Problem With Cenovus Energy Inc. Stock
Matthew DiLallo, The Motley Fool - Motley Fool - Thu Mar 17, 8:45AM CDT
Image source: Cenovus Energy.  Diversified Canadian oil producer Cenvous Energy has a growing financial problem. While it's not as deeply indebted as other oil and gas companies across North America, its financial situation is still pretty...
ECA: 7.62 (-0.02), CVE: 13.69 (-0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

FuboTV Prepares for Q3 2024 Financial Results Release

Updated Category News Views 101

FuboTV to Reveal Q3 2024 Financial Insights FuboTV Inc. (d/b/a Fubo) (NYSE: FUBO), a prominent player in the sports streaming arena, has announced a significant event on the horizon. They will release their third quarter financial results for 2024 early in the market day, a move that provides a valuable update for investors and followers alike. Details about the Financial...

Continue Reading
Coinbase's Gokul Rajaram's Share Sale Highlights Market Trends

Updated Category News Views 262

Gokul Rajaram of Coinbase Sells Shares Recently, Gokul Rajaram, a director at Coinbase Global, Inc. (NASDAQ:COIN), made headlines by selling shares worth $64,536. This transaction took place in September, when he sold 400 shares at a price of $161.34 each. Such moves often attract a lot of attention from those tracking the cryptocurrency market and its developments...

Continue Reading
Robinhood's New Fund Unlocks Private AI Investments for All

Updated Category News Views 200

Robinhood Ventures' Bold Move Into Private AI Investments Robinhood Markets Inc. (NASDAQ: HOOD) is set to revolutionize the investment landscape by giving retail investors access to private startups focused on artificial intelligence (AI). Despite widespread chatter about a potential bubble in the AI sector, the company is moving forward with this innovative approach....

Continue Reading
IRG, PREP, and DWREP Join Forces for Major Site Redevelopment

Updated Category News Views 184

Investment in Future Growth In an exciting development, Industrial Realty Group, LLC (IRG), along with Provider Real Estate Partners (PREP) and DW Real Estate Partners, LLC (DWREP), have embarked on a significant project to redevelop an industrial property in Ohio. The trio has successfully acquired the Hilliard Commerce Center, a sprawling 177,680 square-foot facility...

Continue Reading
Understanding Publicis Groupe’s Recent Share Trading Activity

Updated Category News Views 149

Overview of Share Trading Activities Publicis Groupe recently engaged in notable share trading activities, reflecting its strategic moves in the market. This trading involves shares acquired as part of a pre-approved program by the company's shareholders, aimed at enhancing its capital management. Transaction Details During the latest trading window, Publicis Groupe...

Continue Reading